You have 9 free searches left this month | for more free features.

MagnetisMM-3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Nov 28, 2023

Relapsed or Refractory Multiple Myeloma Trial in Nagoya, Shibuya-ku (Elranatamab (PF-06863135))

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Nagoya, Aichi, Japan
  • +1 more
Jun 20, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

Active, not recruiting
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • Beverly Hills, California
  • +75 more
Oct 4, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
  • +7 more
Jan 9, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Woolloongabba, Queensland, Australia
  • +117 more
Aug 3, 2022

Multiple Myeloma Trial in Montréal (Elranatamab)

Not yet recruiting
  • Multiple Myeloma
  • Montréal, Quebec, Canada
    McGill University Health Centre
Sep 21, 2023

Multiple Myeloma Trial in Beverly Hills (Elranatamab, Carfilzomib)

Recruiting
  • Multiple Myeloma
  • Beverly Hills, California
    Beverly Hills Cancer Center
Dec 21, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab)

Recruiting
  • Multiple Myeloma
  • Fort Collins, Colorado
  • +33 more
Aug 17, 2022

Multiple Myeloma Trial (Elranatamab (PF-06863135))

Temporarily not available
  • Multiple Myeloma
  • Elranatamab (PF-06863135)
  • (no location specified)
Jul 15, 2022

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Benowa, Queensland, Australia
  • +132 more
Jan 24, 2023

Solid Tumor, Adult Trial in China (GT201)

Recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
  • +3 more
Nov 17, 2023

Post COVID-19 Condition (PCC) Trial in E. Amherst, Milan (RDX-19)

Recruiting
  • Post COVID-19 Condition (PCC)
  • RDX-19
  • E. Amherst, New York
  • +1 more
Oct 30, 2023

Olfactory Cleft Stenosis and Obstruction on Paranasal Sinus CT

Recruiting
  • Olfactory Impairment
    • Nancy, France
    • +1 more
    Oct 8, 2023

    Colorectal Cancer Metastatic Trial (Tunlametinib plus Vemurafenib, Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy

    Not yet recruiting
    • Colorectal Cancer Metastatic
    • Tunlametinib plus Vemurafenib
    • Doublets Chemotherapy ± Bevacizumab or Doublets Chemotherapy ± Cetuximab
    • (no location specified)
    Aug 15, 2023

    Skeletal Muscle Fatty Acid Metabolism Trial in Kingston (Fish oil)

    Not yet recruiting
    • Skeletal Muscle Fatty Acid Metabolism
    • Fish oil
    • Kingston, Ontario, Canada
      School of Kinesiology and Health Studies
    Aug 1, 2023

    Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)

    Not yet recruiting
    • Alcohol Use Disorder, Severe
    • Active Comparator: Omega-3
    • Placebo Comparator: olive oil
    • (no location specified)
    Jun 1, 2023

    Solid Tumor, Adult Trial in Tomsk (Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1)

    Enrolling by invitation
    • Solid Tumor, Adult
    • Diagnostic Test: whole body study and SPECT with [99mTc]Tc(CO)3-(HE)3-Ec1
    • Tomsk, Russian Federation
      TomskNRMC
    Jan 23, 2023

    Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)

    Not yet recruiting
    • Concussion, Mild
    • Omega-3
    • Placebo
    • Winnipeg, Manitoba, Canada
      Applied Research Centre, Faculty of Kinesiology, University of M
    Apr 27, 2023

    Tomey OA-2000, Tomey CASIA2, and the LenStar LS900

    Recruiting
    • Cataract
    • +2 more
    • Optical measurement
    • Woburn, Massachusetts
      NorthEast Eye Research Associates
    Sep 26, 2023

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023

    Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

    Recruiting
    • Corneal Epithelial Degeneration
    • TTHX1114(NM141) Ophthalmic Solution
    • Cypress, California
      Trefoil Clinical Site #132
    Mar 3, 2023